Species | Treatment | Seizure/model | Location | Seizure Criteria |
SD Rat Pups (Dubé et al., 2015) | Chronic Early Life Stress | Limbic Spontaneous Seizure | Relative to bregma, A/P: -1.6 mm, L: 3.6 mm and V:-8.4 mm (Right Amygdala) | Behavioral phenominom required, spike duration > than 50 msec, and amplitude > 2 fold the background, duration >6 seconds |
Nestin-TK transgenic aged mice (Cho et. al, 2013) | Pilocarpine (i.p.) | Acute seizure after brain insult | Relative to bregma, A/P: -2.0 mm, L: 2.2 mm, and A/P 1.0 mm and L: 2.0 mm | >3 Hz bursts of spiking activity, >3 seconds, amplitude > 2 X background, convulsive and non-convulsive, confirmed with video |
C57BL/6J mice (Tse et al., 2014) | Kainate (i.p.) | Status Epilepticus | Relative to bregma, A/P: -2.5 mm, L: 2 mm | Behavioral classification (Racine Scale) and power bands |
C57BL/6 mice (Weiergräber et al., 2005) | R/S-baclofen (i.p.) bicucullinemethrobromide 4-AP (i.p.) | Spike/spike wave activity originating from the thalamocortical-corticothhalamic region (R/S baclofen and bicucullinemethrobromide), generalized tonic clonic seizure (4-AP) | Relative to bregma Deep positive lead- A/P: -2mm, L: 2mm (right hemisphere) V: 2 mm (CA3 hippocampus), Negative lead: A/P: - 6.2 mm, L: 0 mm, V: 0 mm Surface positive lead- A/P: -1 mm, L: 1 mm (right hemisphere), negative lead: A/P: -1 mm, L: 1 mm (left hemisphere) | Not listed |
Dunkin Hartley guinea pigs (Crl:HA) (Joosen et al., 2011) | Soman | Organophosphate poisoning | 2 stainless steel screws, relative to breagma-A: 8.0 mm, P:1.2 mm, L: 1 mm | Amplitude >3 X of baseline |
Beagle Dogs (Dürmüller et al. 2007) | Pentylenetetrazole (PTZ) | Proconvulsant risk | Motor cortex, 2 cm apart and 1 cm from the mid-line | EEG activity of a rhythmic aspect, amplitude clearly exceeding background |
Cynomolgus monkeys (Authier et al., 2009) | Pentylenetetrazole (PTZ) | Centrally mediated toxicity | 10-20 system, C3-O1, Cz-Oz, C4-O2 | Automatic seizure analysis and trained reviewer |